New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For AKR;MCD;MPEL;SYT;RHHBY;TSM;DST;AET;ATHN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | all recent news | >>
July 27, 2015
19:37 EDTMCDMcDonald's tests 'open kitchen' in Japan after food scares, RocketNews says
Subscribe for More Information
19:09 EDTSYTSyngenta claims Monsanto breakup fee only applies in limited cases, Reuters says
Subscribe for More Information
13:24 EDTAETRegulators to consider 'too big to fail' in health insurance reviews, CTFN says
Subscribe for More Information
08:10 EDTAETLeerink sees at least 60% chance of Anthem, Cigna deal being approved
Subscribe for More Information
July 26, 2015
18:22 EDTAETMedia reports say Teva to buy Allergan unit as it looks beyond Mylan
Subscribe for More Information
July 24, 2015
16:30 EDTMCDStocks end week lower as Apple headlines busy week of earnings
Subscribe for More Information
10:39 EDTMCDStarbucks hits 52-week high after results top expectations
Subscribe for More Information
07:50 EDTAKRAcadia Realty Trust management to meet with JPMorgan
Subscribe for More Information
July 23, 2015
19:06 EDTATHNOn The Fly: After Hours Movers
UP AFTER EARNINGS: Amazon (AMZN), up 17.2%... Marketo (MKTO), up 15.4%... Juniper Networks (JNPR), up 9.9%... NetGear (NTGR), up 9.2%... Qlik Technologies (QLIK), up 9.1%... LogMeIn (LOGM), up 9.9%... Pandora (P), up 10.3%... Mitek Systems (MITK), up 7.8%... Proofpoint (PFPT), up 5.1%... Supreme Industries (STS), up 4.7%... Skyworks (SWKS), up 3.6%... IGI Laboratories (IG), up 3.7%... Maxim Integrated Products (MXIM), up 4.1%... Boyd Gaming (BYD), up 4.1%... Trinity Industries (TRN), up 5%... Trinity Industries (N), up 3.2%... Starbucks (SBUX), up 4.5%. ALSO HIGHER: Qorvo (QRVO), up 2.7% after Skyworks reported quarterly results. DOWN AFTER EARNINGS: TrueCar (TRUE), down 33.1% after reporting quarterly results and cutting fiscal 2015 revenue guidance... Tripadvisor (TRIP), down 9.2%... Align Technology (ALGN), down 7.4%... Capital One (COF), down 4.9%... PMC-Sierra (PMCS), down 9.1%... athenahealth (ATHN), down 2.1%. ALSO LOWER: Sunesis Pharmaceuticals (SNSS), down 59.7% after giving vosaroxin regulatory update... Avalanche Biotechnologies (AAVL), down 5.6% after CEO Thomas Chalberg, Jr., Ph.D. resigns and Hans Hull name interim CEO.
18:21 EDTMCDOn The Fly: Top stock stories for Thursday
Stocks began the session mixed on the heels of weak earnings reports from both Caterpillar (CAT) and 3M (MMM). The Nasdaq managed to spend most of the day in positive territory but joined the other averages in negative territory by mid-afternoon. Selling picked up momentum towards late afternoon, and by day’s end each of the averages were lower by more than 0.4%, with the Dow losing nearly 0.7%. ECONOMIC EVENTS: In the U.S., initial jobless claims fell to 255,000 in the week ended July 18, below the 278,000 first-time claims that were expected. The Leading Economic Indicators advanced 0.6% in June, exceeding expectations for a 0.3% increase. In Asia, the Shanghai Composite index advanced for a sixth straight session, adding another 2.4%. In Europe, the Greek Parliament voted to accept creditor terms for a new bailout, though a decision on when to reopen Greek financial markets was deferred to next week. COMPANY NEWS: Shares of General Motors (GM) finished the session up 3.96% to $31.50 after reporting earnings per share above analyst expectations. Other notable names rising following earnings reports include SanDisk (SNDK), Under Armour (UA), Southwest (LUV)... Caterpillar, meanwhile, dropped $2.86, or 3.59%, to $76.90 after cutting its yearly guidance during this morning's earnings report, with the company noting a "relatively stagnant" global economy. Also lower following earnings were Comcast (CMCSA, CMCSK), Bristol-Myers Squibb (BMY), Dunkin Brands (DNKN), and Boston Scientific (BSX). MAJOR MOVERS: Among the notable gainers was Cigna (CI), which rose $3.29, or 2.18%, to $154.36 after the Wall Street Journal reported last night that Anthem (ANTM) is nearing a deal to acquire the company for roughly $187, representing a total transaction value of over $48B. Adding to that report, CNBC's David Faber said on Thursday morning that Anthem will announce an agreement Friday to purchase Cigna for $188 per share, at a 45% equity, 55% cash split. Also higher were shares of numerous IT security companies, with FireEye (FEYE) advancing 4.53% and Palo Alto Networks (PANW) adding 2.33% after earnings reports from security firms Fortinet (FTNT) and F5 Networks (FFIV) beat on both top and bottom lines. Fortinet and F5, meanwhile, finished Thursday's session up 10.71% and 7.75% to $46.83 and $127.68, respectively. Among the noteworthy losers following earnings was McDonald's (MCD), which edged down 0.52% to $97.10 after noting that Q2 global comparable sales fell 0.7% for the quarter, including a 2% decline in U.S. same-store sales. Also lower was Hertz (HTZ), which declined 8.53% to $16.45 following a downgrade to Underweight at Morgan Stanley, with the research firm citing increased competition from Uber and similar mobility services. INDEXES: The Dow fell 119.12, or 0.67%, to 17,731.92, the Nasdaq lost 25.36, or 0.49%, to 5,146.41, and the S&P 500 declined 12.00, or 0.57%, to 2,102.15.
16:20 EDTATHNathenahealth backs FY15 adjusted EPS $1.10-$1.20, consensus $1.18
Sees FY15 adjusted EPS at or above mid-point of $1.10-$1.20 range. Backs FY15 revenue $905M-$925M, consensus $917.36M. Sees revenue at or above mid-point of guidance range. Backs FY15 adjusted gross margin 62.5%-63.5%. Sees adjusted gross margin at or above mid-point of guidance range.
16:17 EDTATHNathenahealth reports Q2 adjusted EPS 32c, consensus 25c
Subscribe for More Information
15:22 EDTMCDDunkin' CEO: 'Don't think we need to respond' if McDonald's expands breakfast
Subscribe for More Information
15:04 EDTATHNNotable companies reporting after market close
Subscribe for More Information
12:43 EDTATHNathenahealth technical comments ahead of earnings news
Subscribe for More Information
12:32 EDTMCDOn The Fly: Top stock stories at midday
Subscribe for More Information
11:28 EDTMCDMcDonald's sees foreign exchange to negatively impact FY15 EPS by 45c
McDonald's sees foreign exchange to negatively impact Q3 EPS by 14c-16c.
11:25 EDTMCDMcDonald's says will make dividend announcement in November
Subscribe for More Information
11:23 EDTMCDMcDonald's says took U.S. price increase at end of May
Subscribe for More Information
11:18 EDTMCDMcDonald's reiterates plan to return $8B-$9B to shareholders in 2015
Subscribe for More Information
11:16 EDTMCDMcDonald's sees net addition of about 300 restaurants in 2015
Subscribe for More Information
11:04 EDTMCDMcDonald's sees positive global comparable sales in Q3
McDonald's President and CEO Steve Easterbrook said earlier that the company has made "meaningful progress" since announcing the initial steps of its turnaround plan in early May. "To position the business for long-term growth, we've undergone significant organizational change and are streamlining our global resources to improve our efficiency and effectiveness. While our second quarter results were disappointing, we are seeing early signs of momentum. Looking ahead to third quarter, we expect positive global comparable sales led by growth in our newly-created International Lead Market segment and China's continuing recovery from the 2014 APMEA supplier issue," Easterbrook added.
10:43 EDTATHNathenahealth NY Presbyterian win shows enterprise not waning, says Piper Jaffray
Subscribe for More Information
10:38 EDTATHNathenahealth selected by NewYork-Presbyterian Physician Services Organization
NewYork-Presbyterian announced earlier a new collaboration with athenahealth. NewYork-Presbyterian, through its Physician Services Organization, will provide the NewYork-Presbyterian Medical Groups management of their physician practices via implementation of athenahealth's electronic health record, practice management, and patient engagement services for more than 800 physicians and an additional 300 licensed professionals. Initial deployment of athenahealth services will begin at NewYork-Presbyterian Medical Group/Hudson Valley, NewYork-Presbyterian Medical Group/Queens, and NewYork-Presbyterian Medical Group/Westchester with future implementation to follow in Brooklyn and other areas in the region.
09:18 EDTSYTDow Chemical says it would be interested in Syngenta seeds unit
Subscribe for More Information
08:00 EDTMCDMcDonald's reports Q2 global comparable sales down 0.7%
Reports Q2 global comparable sales down 0.7%, reflecting negative guest traffic in all major segments. Reports Q2 US comparable sales down 2%, reflecting negative guest traffic as the featured products and promotions did not achieve expected consumer response amid ongoing competitive activity. Reports Q2 Europe comparable sales up 1.2% driven by solid performance in the U.K. and Germany, partly offset by negative results in France. Reports Q2 APMEA comparable sales down 4.5%, primarily due to the impact of prolonged, broad-based consumer perception issues in Japan along with negative performance in China and other Asian markets, partly offset by strong performance in Australia.
07:59 EDTMCDMcDonald's reports Q2 EPS $1.26, consensus $1.24
Subscribe for More Information
07:32 EDTMPELLas Vegas Sands results encouraging, says Stifel
After Las Vegas Sands (LVS) reported higher than expected Macau property-level EBITDA, Stifel says that the beat should cause analysts to raise their estimates for the company. The firm adds that the results are encouraging for all "Macau-centric operators." It raised its price target on Las Vegas Sands to $65 from $60 and keeps a Buy rating on the shares. Other companies with a major presence in Macau include Melco Crown (MPEL), Wynn Resorts (WYNN), and MGM (MGM).
07:03 EDTDSTDST Systems reports Q2 non-GAAP EPS $1.39, consensus $1.41
Subscribe for More Information
06:27 EDTRHHBYRoche CEO expects biosimilars in Europe by late 2017, Reuters reports
Subscribe for More Information
06:21 EDTSYTMonsanto renews takeover efforts after Syngenta's Q2 results, Reuters says
Subscribe for More Information
05:46 EDTRHHBYRoche expects FY15 sales to grow low- mid-single digits
Expects FY15 core EPS to grow ahead of sales at constant exchange rates. Roche expects to further increase dividend in Swiss francs.
05:45 EDTRHHBYRoche reports 1H15 core EPS CHF 7.22 vs. 7.57 last year
Subscribe for More Information
July 22, 2015
15:26 EDTMCDNotable companies reporting before tomorrow's open
Subscribe for More Information
13:51 EDTMCDMcDonald's technical comments before results
Subscribe for More Information
13:19 EDTMCDEarnings Watch: McDonald's to report Q2 earnings as company seeks revival
Subscribe for More Information
08:43 EDTAETAetna positioned to report good Q2 results, says BMO Capital
Subscribe for More Information
08:25 EDTMCDMcDonald's July weekly volatility elevated into Q2 and outlook
Subscribe for More Information
July 21, 2015
18:29 EDTMCDMcDonald's may offer all-day breakfast nationwide in October, WSJ reports
Subscribe for More Information
10:24 EDTTSMOptions with decreasing implied volatility
Subscribe for More Information
07:05 EDTRHHBYOphthotech names Shima as Chief Scientific Officer, Bjarke as CCO
Subscribe for More Information
July 20, 2015
10:00 EDTDSTOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:24 EDTMCDMcDonald's U.S. outlook improving, says RBC Capital
Subscribe for More Information
07:33 EDTRHHBYInternational AIDS Society to hold a conference
Subscribe for More Information
07:23 EDTDSTDST Systems downgraded to Neutral from Outperform at Baird
Baird downgraded DST Systems to Neutral based on strong year-to-date performance and raised its price target on shares to $138 from $130.
05:13 EDTRHHBYRoche expands HIV Global Access Program
Roche announced an expansion to the HIV Global Access Program to include early infant HIV diagnostic testing for low and middle income countries. Roche, in partnership with the Joint United Nations Programme on HIV/AIDS, or UNAIDS, the Clinton Health Access Initiative, or CHAI, UNITAID, the U.S. President's Emergency Plan For AIDS Relief, or PEPFAR, and the Global Fund to fight AIDS, TB and Malaria, is committed to working with the Diagnostics Access Initiative by providing state-of-the-art solutions to achieve the 90-90-90 goal set forth by UNAIDS. Announced in 2014, the HIV Global Access Program is Roche's most recent addition to the AmpliCare Initiative, which launched in 2002 in South Africa.
July 19, 2015
17:37 EDTSYTSyngenta plans investor meetings over rejected Monsanto offer, WSJ says
Subscribe for More Information
15:54 EDTTSMTSMC confirms 10nm mass production in 1Q17, DigiTimes says
Subscribe for More Information
14:09 EDTTSMIntel chip delay could spell opportunity or disaster, Barron's says
Subscribe for More Information
July 17, 2015
08:17 EDTSYTMonsanto CEO tells CNBC 'miles to go' on Syngenta deal
Subscribe for More Information
07:44 EDTSYTMonsanto COO: Hostile Syngenta takeover 'some way off,' Reuters says
Monsanto (MON) president and COO Brett Begemann said that any hostile bid for Syngenta (SYT) is "some way off," Reuters reports, citing an interview with Begemann. Monsanto said it is more interested in Syngenta's research capabilities, product liability exposure, and te quality of its reported sales, meaning taking an offer directly to the company's shareholders was "not a very compelling idea," the report says. Reference Link
July 16, 2015
19:32 EDTMCDMcDonald's franchisees indicate lowest 6-month outlook in 12 years, WSJ says
Subscribe for More Information
19:17 EDTAETAffordable Care Act plan prices to increase 11.2% in 2016, WSJ says
State regulators will begin approving plan price increases for insurance plans purchased on Care Act’s exchanges as early as this month, reports the Wall Street Journal. Nearly every state has plans with premiums increasing over 10%, with some as high as 30%-50%, the Journal adds. Publicly traded companies in the space include Aetna (AET), Anthem (ANTM), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG). Reference Link
13:43 EDTTSMSemi equipment stocks overreacting to Intel capex cut, says Summit Research
Summit Research said Intel (INTC) is pushing out its 10nm plans for multiple reasons and that TSMC (TSM) and Samsung (SSNLF) will not let a "once in a lifetime opportunity" pass and will speed up their own spending. The firm believes the pullback in semiconductor equipment stocks, particularly Applied Materials (AMAT), KLA-Tencor (KLAC) and Lam Research (LRCX), on Intel's capex guidance cut is somewhat of an overreaction and recommends buying amid the weakness.
13:11 EDTTSMSemiconductor equipment stocks fall after Intel cuts CapEx view
Subscribe for More Information
12:48 EDTTSMLam Research sell-off on Intel capex cut an overreaction, says Stifel
Subscribe for More Information
11:41 EDTTSMTSMC slips after reporting Q2 results, cautious outlook
Subscribe for More Information
10:00 EDTATHN, MCDOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:44 EDTSYTMonsanto-Syngenta tie-up needs many concessions, WSJ reports
Subscribe for More Information
06:15 EDTATHNathenahealth initiated with a Hold at Canaccord
Target $125.
05:46 EDTTSMTSMC and Samsung begin A9 chip mass production, DigiTimes reports
Subscribe for More Information
July 15, 2015
16:20 EDTMCDMcDonald's initiated with a Neutral at BTIG
Subscribe for More Information
09:07 EDTMCDMcDonald's turnaround to take years, Peltz says on CNBC
Subscribe for More Information
09:06 EDTMCDPeltz says if didn't own Wendy's, McDonald's may be investment
Subscribe for More Information
08:53 EDTAETAetna decline creates favorable entry point, says Argus
Subscribe for More Information
07:45 EDTSYTSenator urges Monsanto to reconsider inversion if Syngenta deal succeeds
U.S. Senator Dick Durbin announced that in a meeting with Monsanto (MON) CEO Hugh Grant, Durbin urged the company to keep its United States tax address if its intended acquisition of Syngenta (SYT) succeeds. “Like so many large companies in the U.S., Monsanto has prospered in large part due to U.S. taxpayer-funded programs and services... I urged Monsanto CEO High Grant to reconsider the company’s corporate inversion plans to move its tax address to Europe. I also made it very clear that I will do all I can in Congress to close the loophole that allows corporations to avoid their U.S. tax responsibility,” said Durbin.
05:53 EDTTSMTSMC cuts 28nm and 20nm prices by 5%-10%, DigiTimes reports
Subscribe for More Information
July 14, 2015
16:51 EDTSYTPaulson takes stake in Syngenta to support Monsanto merger, Bloomberg says
Subscribe for More Information
16:42 EDTSYTPaulson builds Syngenta stake to back Monsanto deal, Bloomberg says
Subscribe for More Information
07:27 EDTAETAetna in best position among health insurers for earnings beat, says Wells Fargo
Wells Fargo believes that Aetna is in the best position among health insurers to report better than expected earnings. The firm says that the company's cost trend remains manageable and below guidance. It keeps an Outperform rating on the shares.
06:04 EDTRHHBYRoche says atezolizumab met primary endpoint in IMvigor 210 trial
Roche announced that in the IMvigor 210 study, the investigational cancer immunotherapy atezolizumab shrank tumors -- objective response rate, ORR, the primary end point of this Phase II study -- in people with locally advanced or metastatic urothelial bladder cancer who had progressed on initial treatment. High amounts of PD-L1 expression by a person’s cancer correlated with increased response to the medicine. Adverse events were consistent with what has been previously observed for atezolizumab. Sandra Horning, M.D., chief medical officer and head of Global Product Development, said, “We plan to present results at an upcoming medical meeting and will discuss next steps with health authorities to bring a new treatment option to patients as soon as possible.” Last year, the U.S. FDA granted Breakthrough Therapy Designation for atezolizumab in people whose metastatic bladder cancer expressed PD-L1. This designation is designed to expedite the development and review of medicines intended to treat serious diseases. In addition to the IMvigor 210 study, Roche has an ongoing randomised Phase III study, IMvigor 211, comparing atezolizumab with standard-of-care chemotherapy in people who have relapsed UBC, and a planned Phase III study, IMvigor 010, that will evaluate atezolizumab compared with observation in people with early-stage muscle-invasive bladder cancer who are selected for PD-L1 expression and are at risk for recurrence.
July 13, 2015
09:49 EDTAET$1,000 per dose drugs found "cost effective," Bloomberg reports
Health insurers will face pressure to cover hepatitis C drugs with list prices of $1,000 per daily dose after a report from the American Association for the Study of Liver Diseases and the Infectious Diseases Society of America suggests that such medications are "cost effective," Bloomberg reports. While insurance companies already cover the sickest patients for treatments by Gilead (GILD) and AbbVie (ABBV), they've avoided extending coverage to those not yet showing damage from the disease, the report says. Publicly traded companies in the health insurance sector include Aetna (AET), Anthem (ANTM), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG). Reference Link
08:59 EDTAETLeerink managed care analyst has an analyst/industry conference call
Healthcare Facilities/Managed Care Analyst Gupte, along with Manatt Health Solutions Managing Director Joel Ario, J.D., discuss the recent changes in the Managed Care industry and the regulatory/competitive implications of these changes on an Analyst/Industry conference call to be held on July 13 at 1 pm.
07:46 EDTMPELMacau government may soften casino smoking ban, Macau Business says
Subscribe for More Information
07:44 EDTRHHBYEli Lilly price target raised to $105 from $100 at Jefferies
Subscribe for More Information
<< 1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use